
Doctor C Michael Gibson
Harvard Medical School, Boston (United States of America)
Membership:
ESC Professional Member
Biography
C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher & educator. He is the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School. The institutes have led over 1,000 studies, published 3,000 manuscripts in the peer review literature, and have led 60 FDA submissions from their network of 7,000 sites worldwide.
In 2014, 2018 - 2020 Gibson was ranked as one of the world's most highly cited authors in all of science in the past decade by Thomson Reuters. His work has been cited over 107,000 times, and he has an H index of 118 and an i10-index of 469.
Dr. Gibson obtained his BS, MS, and MD degrees at the University of Chicago where he was a Phi Beta Kappa and AOA graduate.
Contributor content
Session
Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances
30 August 2025
Session
HOT LINE 6
1 September 2024
Session
ESC TV Conversations: spirituality in cardiovascular medicine
31 August 2024
Session
Plaque erosion: an important mechanism of ACS: current concepts and contemporary management
29 August 2022
Session
HOT LINE SESSION 5
28 August 2022
Session
Guidelines in Practice: antithrombotic therapy in atrial fibrillation and acute myocardial infarction
27 August 2021
Session
Coronary artery disease - Epidermiology, prognosis and outcome
3 September 2019
Session
Be scientific and unique on Twitter
3 September 2019
Session
Cardiovascular innovation: the next frontier
2 September 2019
Session
The ORION Program - What to look for in ORION-11
1 September 2019

